Overactive Bladder Study
Study Purpose: To evaluate the safety and efficacy of study drug compared to placebo for the treatment of urinary incontinence.
Basic Eligibility Criteria:
- Male and female participants over the age of 18
- Participant to weigh more than 88 lbs
- Participant has diagnosed documented MS history, but stable for 3 or more months
- Urinary incontinence not adequately controlled by anticholinergic medication
| Clinical Trials: Current and Upcoming | |
|
Alzheimer's
Cervical Dystonia Fibromyalgia Multiple Sclerosis Overactive Bladder Seizures Spasticity Cluster Headache |
Back Pain
Neuropathy Migraines Optic Neuritis Parkinson's Disease Postherpetic Neuralgia Stroke Sinusitis |
If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:
Angelo Termine, M.S.M. , M.B.A. , Clinical Research Manager, at [email protected]
Patricia Mennona , Clinical Research Administrative Assistant at [email protected]
Clinical Research Coordinators:
Grace Valentin at mailto:[email protected]
Alicia Castelot at [email protected]
Kayla Kennedy at [email protected]
Lisa Lazarecki at [email protected]
Maxine Kuang at [email protected]
You may also call 203.333.1151 and we will be happy to answer any of your questions.